Format

Send to

Choose Destination
BMJ. 2003 Jul 12;327(7406):75.

Extracorporeal shock wave therapy for plantar fasciitis: randomised controlled multicentre trial.

Author information

1
Orthop├Ądische Klinik, Universit├Ąt Regensburg, 93077 Bad Abbach, Germany. m.haake@rheumaortho-zentrum.de

Abstract

OBJECTIVE:

To determine the effectiveness of extracorporeal shock wave therapy compared with placebo in the treatment of chronic plantar fasciitis.

DESIGN:

Randomised, blinded, multicentre trial with parallel group design.

SETTING:

Nine hospitals and one outpatient clinic in Germany.

PARTICIPANTS:

272 patients with chronic plantar fasciitis recalcitrant to conservative therapy for at least six months: 135 patients were allocated extracorporeal shock wave therapy and 137 were allocated placebo.

MAIN OUTCOME MEASURES:

Primary end point was the success rate 12 weeks after intervention based on the Roles and Maudsley score. Secondary end points encompassed subjective pain ratings and walking ability up to a year after the last intervention.

RESULTS:

The primary end point could be assessed in 94% (n=256) of patients. The success rate 12 weeks after intervention was 34% (n=43) in the extracorporeal shock wave therapy group and 30% (n=39) in the placebo group (95% confidence interval - 8.0% to 15.1%). No difference was found in the secondary end points. Few side effects were reported.

CONCLUSIONS:

Extracorporeal shock wave therapy is ineffective in the treatment of chronic plantar fasciitis.

PMID:
12855524
PMCID:
PMC164919
DOI:
10.1136/bmj.327.7406.75
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center